中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
—— |
7-[4-O-(2,6-dideoxy-3-C-methyl-α-L-ribo-hexopyranosyl)-3-azido-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]daunorubicinone |
—— |
C34H39N3O13 |
|
—— |
7-[4-O-(3-azido-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)-3-azido-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]daunorubicinone |
—— |
C33H36N6O12 |
|
—— |
7-[4-O-(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-3-azido-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]daunorubicinone |
—— |
C34H39N3O13 |
|
—— |
N-<4-(L-glutamylcarbonyloxy)benzyloxycarbonyl>daunorubicin |
—— |
C41H42N2O18 |
|
—— |
7-[3-(4-hydroxymethyl-[1,2,3]triazol-1-yl)-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]daunorubicinone |
—— |
C30H31N3O11 |
|
—— |
10-O-(α-oleaudropyranosyl)daunorubicinone |
—— |
C28H30O11 |
|
—— |
7-[4-O-(2,3,6-trideoxy-α-L-erythro-hexopyranosyl)-3-azido-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]daunorubicinone |
—— |
C33H37N3O12 |
|
—— |
7-[3-[4-(4-hydroxybutyl)-[1,2,3]triazol-1-yl]-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]daunorubicinone |
—— |
C33H37N3O11 |
|
—— |
10-O-(α-amicetopyranosyl)daunorubicinone |
—— |
C27H28O10 |
|
—— |
10-O-(4-azido-2,3,4,6-tetradeoxy-α-L-erythro-hexopyranosyl)daunorubicinone |
—— |
C27H27N3O9 |
|
—— |
7-[3-amino-4-O-(β-L-oleandrsyl)-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]daunorubicinone |
—— |
C34H41NO13 |
|
—— |
7-[3-[4-(2-hydroxyethyl)-[1,2,3]triazol-1-yl]-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]daunorubicinone |
—— |
C31H33N3O11 |
|
—— |
7-[3-amino-4-O-(α-L-rhamnopyranosyl)-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]daunorubicinone |
—— |
C33H39NO14 |
|
—— |
7-[3-[4-(3-hydroxypropyl)-[1,2,3]triazol-1-yl]-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]daunorubicinone |
—— |
C32H35N3O11 |
|
—— |
daunorubicin-3'-NH-(E)-1-(p-acetylphenyl)-1,2-bis(p-methoxyphenyl)-1-butene |
—— |
C53H53NO14 |
|
—— |
3'-N-pyruvoyl-daunomycin |
—— |
C30H31NO12 |
|
—— |
Dauno-MBS |
—— |
C38H34N2O13 |
|
—— |
3'-N-[(N-acetyl)-β-aspartyl]-daunomycin |
—— |
C33H36N2O14 |
|
—— |
N-<4-(dipropen-2-yl-L-glutamylcarbonyloxy)benzyloxycarbonyl>daunorubicin |
—— |
C47H50N2O18 |
|
—— |
daunomycin 14-pyruvate hydrochloride |
—— |
C30H31NO13*ClH |
|
—— |
N3'-acetyl-4'-epidoxorubicin |
—— |
C29H31NO12 |
|
—— |
4'-ketone-N-trifluoroacetyl-14-O-tert-butyldimethylsilyl-adriamycin |
—— |
C35H40F3NO12Si |
|
—— |
N-trifluoroacetyl-14-O-tert-butyldimethylsilyl-adriamycin |
—— |
C35H42F3NO12Si |
|
—— |
N-trifluoroacetyl-epirubicin |
—— |
C29H28F3NO12 |
|
—— |
epidoxoform |
—— |
C57H58N2O22 |
|
—— |
(8S,10S)-1-amino-6,8,11-trihydroxy-8-(hydroxyacetyl)-10-{[(1S,3R,4aS,9S,9aR,10aS)-9-methoxy-1-methyloctahydro-1H-pyrano[4’,3’:4,5][1,3]oxazolo[2,3-c][1,4]oxazin-3-yl]oxy}-7,8,9, 10-tetrahydrotetracene-5,12-dione |
—— |
C31H34N2O12 |
|
—— |
doxazolidine butyl carbamate |
—— |
C33H37NO13 |
|
—— |
butyl 4-(N-doxazolidinylcarbonyloxymethyl)phenylcarbamate |
—— |
C41H44N2O15 |
|
—— |
N-[2-(4-(doxorubicin-3'-N-yl)-4-oxobutanoylamino)-ethyl]-succinamic acid N-hydroxysuccinimidyl ester |
—— |
C41H46N4O18 |
|
—— |
N-(all-trans-retinoyl)doxorubicin |
—— |
C47H55NO12 |
|
—— |
N-(2-hydroxyethyl)doxorubicin |
—— |
C29H33NO12 |
|
—— |
N-succinimidyl 6-(doxorubicin-3'-N-yl)-5-oxohexanoate |
—— |
C37H40N2O16 |
|
—— |
13-(R,S)-dihydrodaunorubicin |
28008-55-1 |
C27H31NO10 |
|
—— |
H2N-Ala-Leu-Ala-Leu-DNR |
—— |
C45H61N5O14 |
|
—— |
5,12-bisdeoxy-13-dihydrodaunorubicin |
—— |
C27H31NO8 |
|
—— |
12-deoxy-13-dihydrodaunorubicin |
—— |
C27H31NO9 |
|
—— |
N-[4-(daunorubicin-N-carbonyloxymethyl)phenyl] O-β-D-glucopyranuronosyl carbamate sodium salt |
—— |
C42H43N2O20*Na |
|
—— |
15-demethoxy-aclacinomycin T |
—— |
C29H33NO10 |
|
—— |
2-deoxy-L-fucosyl-2-deoxy-L-fucosyl-rhodosaminyl-aklavinone |
—— |
C42H55NO16 |
|
—— |
doxorubicin 4-[(3-{[4-nitro-3-trifluoromethyl-phenyl]amino}propyl)carbamoyl]benzoate |
—— |
C45H43F3N4O15 |
|
—— |
N-acetyl-3-({3-[(2E)-2-{2-hydroxy-1-[(2S,4S)-2,5,12-trihydroxy-7-methoxy-4-{[(1S,3R,4aS,9S,9aR,10aS)-9-methoxy-1-methyloctahydro-1H-pyrano[4,3':4,5][1,3]oxazolo[2,3-c][1,4]oxazin-3-yl]oxy}-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethylidene}hydrazinyl]-3-oxopropyl}disulfanyl)-L-alanine |
—— |
C40H48N4O16S2 |
|
—— |
N'-{(1E)-2-hydroxy-1-[(2S,4S)-2,5,12-trihydroxy-7-methoxy-4-{[(1S,3R,4aS,9S,9aR, 10aS)-9-methoxy-1-methyloctahydro-1H-pyrano[4',3:4,5][1,3]oxazolo[2,3-c][1,4]oxazin-3-yl]oxy}-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethylidene}-3-(pyridin-2-yldisulfanyl)propaneliydrazide |
—— |
C40H44N4O13S2 |
|
—— |
MEN10733 |
—— |
C33H39NO13 |
|
—— |
MEN10732 |
—— |
C33H39NO13 |
|
—— |
(7S,9S)-7-<(3'-amino-2',3',6'-trideoxy-α-L-lyxohexopyranosyl)oxy>-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(N-phenylcarbamoyl)-5,12-naphthacenedione |
—— |
C31H30N2O9 |
|
—— |
7-[3-amino-4-O-(β-L-mycarosyl)-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]daunorubicinone |
—— |
C34H41NO13 |
|
—— |
7-[4-O-(2,6-dideoxy-α-L-arabino-hexopyranosyl)-3-azido-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]daunorubicinone |
—— |
C33H37N3O13 |
|
—— |
WP755 |
—— |
C34H34N2O12 |
|
—— |
6-{[(1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-naphthacenyl]oxy}-3,4,5-trihydroxytetrahydro-2H-pyrancarboxylic acid |
—— |
C26H24O13 |
|
—— |
10-O-(α-L-cladinosyl)daunorubicinone |
—— |
C29H32O11 |
|